Sample size estimates for drug-drug interaction (DDI) studies are often based on variability information from the literature or from historical studies, but small sample sizes in these sources may limit the precision of the estimates obtained. This project aimed to create an intra-subject variability library of the pharmacokinetic (PK) exposure parameters, area under the curve, and maximum plasma concentration, for probes commonly used in DDI studies. Data from 66 individual DDI studies in healthy subjects relating to 18 common probe substrates were pooled to increase the effective sample size for the identified probes by 1.5- to 9-fold, with corresponding improvements in precision of the intra-subject PK variability estimates in this libra...
This study is to assess pharmacokinetic (PK) sampling time schedules and trial size requirements of ...
International audienceDuring the drug development process, phase I trials are the first occasion to ...
Drug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of in-tense sc...
Abstract: Preclinical and clinical pharmacokinetic (PK) profiling is the bottleneck of the drug deve...
Physiologically-based pharmacokinetics (PBPK) modeling is a robust tool that supports drug developme...
Pharmacodynamics (PD) examines the relationship between drug concentration and onset, intensity, and...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
<p>The table displays the estimated pharmacokinetic parameter estimates for healthy individuals. Int...
Accurately discriminating changes in clearance (CL) from changes in bioavailability (F) following an...
Many drug-drug interactions (DDIs) are based on alterations of the plasma concentrations of a victim...
According to the current bioavailabilityhioequivalence regulations by the Food arid Drug Administrat...
In contemporary medicine, the continuous introduction of new medicines to the market has significant...
Contains fulltext : 169462.pdf (publisher's version ) (Open Access)Pharmacokinetic...
The oral route of drug administration is the most convenient method of drug delivery, but it is asso...
Abstract. Pharmacokinetic drug-drug interactions (DDIs) can lead to undesired drug exposure, resulti...
This study is to assess pharmacokinetic (PK) sampling time schedules and trial size requirements of ...
International audienceDuring the drug development process, phase I trials are the first occasion to ...
Drug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of in-tense sc...
Abstract: Preclinical and clinical pharmacokinetic (PK) profiling is the bottleneck of the drug deve...
Physiologically-based pharmacokinetics (PBPK) modeling is a robust tool that supports drug developme...
Pharmacodynamics (PD) examines the relationship between drug concentration and onset, intensity, and...
When drug interference is suspected, a pharmacokinetic study is safer for patients than a large-sca...
<p>The table displays the estimated pharmacokinetic parameter estimates for healthy individuals. Int...
Accurately discriminating changes in clearance (CL) from changes in bioavailability (F) following an...
Many drug-drug interactions (DDIs) are based on alterations of the plasma concentrations of a victim...
According to the current bioavailabilityhioequivalence regulations by the Food arid Drug Administrat...
In contemporary medicine, the continuous introduction of new medicines to the market has significant...
Contains fulltext : 169462.pdf (publisher's version ) (Open Access)Pharmacokinetic...
The oral route of drug administration is the most convenient method of drug delivery, but it is asso...
Abstract. Pharmacokinetic drug-drug interactions (DDIs) can lead to undesired drug exposure, resulti...
This study is to assess pharmacokinetic (PK) sampling time schedules and trial size requirements of ...
International audienceDuring the drug development process, phase I trials are the first occasion to ...
Drug-drug interaction (DDI) is a major cause of morbidity and mortality and a subject of in-tense sc...